At the world’s most influential meeting on HIV research and science, and their applications, ICAP experts will present results from a wide range of studies in HIV prevention, care, and treatment conducted around the world. Please see below for a summary of ICAP’s presence at the 13th International AIDS Conference (July 13-17, Kigali, Rwanda).

Click for IAS 2025 conference information

All times listed are CAT (Central Africa Time).

---

Satellite

Leading the way: Rwanda’s groundbreaking achievements in reaching UNAIDS global HIV targets ahead of time

July 14 | 1:00 pm – 2:30 pm

Rwanda has emerged as a global leader in the fight against HIV/AIDS, demonstrating that a comprehensive, inclusive, and innovative response can significantly reduce the burden of the epidemic. By achieving the UNAIDS 95-95-95 targets ahead of the 2030 deadline, Rwanda has set a precedent for other nations, showcasing that commitment, political will, and community-centered approaches can transform public health outcomes. This session seeks to highlight Rwanda’s journey, focusing on the strategies, policies, and partnerships that contributed to these successes. It also aims to inspire and inform global stakeholders on how to replicate and scale up these best practices in their contexts.

ICAP Presentation

The Impact of Global Partnerships in Achieving Progress: Learning from the Past to Shape the Future: Highlighting Partners’ Contribution to Rwanda’s National HIV Program Implementation

Wafaa El-Sadr, MD, MPH, MPA, global director, ICAP at Columbia University, and executive vice president, Columbia Global

1:15 pm

11:30 am -12:30 pm

Capturing Young Women’s Voices, Contraception Use, and HIV Prevention Practices Using Dynamics of Contraception in Eswatini (DYCE): Protocol for a High-Frequency, Longitudinal Cell Phone Survey

Zandile Masangane, ICAP in Eswatini

 

For more information on this session, click here.

---

Poster Exhibitions 

Leveraging social network analysis to support epidemiological research on HIV prevention and case management — S. Karera, B. Kwizera, F.K. Rubuga, E. Remera, G. Rwibasira, C. Kamanzi, G. Gatete, C. Steiner, V. Mugisha

Effectiveness and cost of community-based dried blood spot sample collection for early infant diagnosis in Angola — W. Reidy, S. Saito, H. Liu, A. Dias, L. Chauca, R. Nunes, M.L. Furtado, B. Pocongo, M.d.R. Marques, F.L. Velho, F. Manuel, R.C. Branco, T. Soraya, G. Manuel, A. Macama, R. Fayorsey

Treatment interruption surpasses virological failure as barrier to HIV viral suppression in sub-Saharan Africa (2020-2023) — M. Farahani, S. Saito, S.M. Farley, T.F. Smart, R.K. Nyirenda, L. Maile, O. Mugurungi, W.L. Kirungi, E.S. Gudo, P.F. Njau, W. Hladik, H.K. Patel, A.C. Voetsch, S. Sendagala, T. Maphosa, M. Pasipamire, A. Kailembo, W.M. El-Sadr

Contribution of HIV recent infection cluster investigation strategy in closing gaps of HIV testing: Lessons learned and public health interventions in Rwanda — B. Kwizera, E. Mpabuka, C. Kamanzi, S. Karera, V. Mugisha, G. Rwibasira, B. Ikuzo

Institutionalization of Quality Improvement projects to improve ART service delivery in Rwanda — Ingabire Angeline, Brian Kwizera; Uwungutse Madeleine, Isabelle Ntaganda, Collins Kamanzi, Veronicah Mugisha, Gisele Mujawamariya, Gallican Rwibasira

Prevalence of mpox virus among men who have sex with other men in Kenya — E. Pascal Mwore, J. Zech, J. Walimbwa, S. Wambua

Pregnancy outcomes in the multicentre CoVPN 3008 (Ubuntu) COVID-19 vaccine trial among people with HIV in East and Southern Africa — V.C. Bailey, A. Tapley, J. Andriesen, J.J. Kee, B. Mabilane, S. Hendricks, E. Kamuti, H. Nuwagaba-Biribonwoha, J. Makhema, T. Samandari, P.J. Elyanu, L. Polakowski, M. Yacovone, M. Villaran, Y. Huang, P. Kotze, N. Garrett, S. Dadabhai, N. Mgodi, Z. Chirenje

---

E-Posters 

An assessment of Advanced HIV Disease: clinical and epidemiological insights from Burundi — Claver Habonimana, Nestor Ntakaburimvo, Straso Jovanovski, Bonaparte Nijirazana, Aimé Ndayizeye, Hamidou Nzomwita, Jean Bosco Nsengiyumva, Emile Ndayiragije, Christelle Kaze, Jean-Jacques Kouassi M’Bea, Ruby Fayorsey, Million Tesema, Greet Vandebriel, Eugenie Poirot

Prevalence and factors associated with Advanced HIV Disease among newly diagnosed people living with HIV in Rwanda, 2020-2023: implications on screening, prevention, and management —Brian Kwizera, Steven Karera, Veronicah Mugisha, Gallican Rwibasira, Gisele Mujawamariya, Samuel S. Malamba, Richard C.N. Mwesigwa, Celestine Nyagatare, Jackson Sebeza, Tom Oluoch, Elfriede Agyemang

Qualitative assessment of health system barriers to access of HIV services by men who have sex with men (MSM) in Rwanda — Kamanzi Collins, Mugisha Veronicah, Rwibasira Gallican, Ikuzo Basile, Mujawamariya Giselle

“It seemed like something I couldn’t ask for:” a qualitative analysis of cis- and transgender women’s experiences along the PrEP cascade in the South Bronx, New York City — T. Abularrage, J. Franks, C. Wright, A. Kahn, S. Edwards, T. Chern, H. Harpaldas, S. Sia, E. Morrison, J. Justman

Making PrEP Smart: Persistence, Use, and Acceptability of a PrEP Adherence and HIV-Self Testing App Among Women in the South Bronx, New York City — Connor Wright, Terry Chern, Tara F. Abularrage, Julie Franks, Ann Kahn, Shakir Edwards, Harshit Harpaldas, Rashaunna Redd, Alex Yin2, Siddarth Arumugam, Robert Stanciu, Sam Sia, Ellen Morrison, Jessica E. Justman

Correlates of viral suppression among adolescents living with HIV in Mozambique: results from a multi-center cross-sectional study — Joana Falcao, Elaine J. Abrams, Aleny Couto, Allison Zerbe, Eduarda Pimentel De Gusmao, Kelvin Manuel, Niklaus D. Labhardt

---

Oral Abstract Presentation

Examining unmet PrEP need and PrEP equity among young people using pooled data from three African countries, October 2023-September 2024 — Sarah Wallach
Session title: Zero AIDS-related deaths: Scaling up advanced HIV disease response
Session date: Tuesday, 15 July 2025
Session time: 16:30 – 17:30
Session room: MH4

Click here for more program information